Placental cord drainage impact on third stage of labor: A randomized controlled trial.

Active management Placental cord drainage Postpartum hemorrhage Randomized controlled trial Third stage of labor

Journal

American journal of obstetrics & gynecology MFM
ISSN: 2589-9333
Titre abrégé: Am J Obstet Gynecol MFM
Pays: United States
ID NLM: 101746609

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 01 06 2024
revised: 13 07 2024
accepted: 16 07 2024
medline: 5 8 2024
pubmed: 5 8 2024
entrez: 4 8 2024
Statut: aheadofprint

Résumé

The third stage of labor is a pivotal phase in obstetric care. Management may be physiological or active. Although the use of prophylactic placental cord drainage has been assessed in prior data, there is still no clear-cut evidence supporting its effectiveness in improving key obstetric outcomes. The aim of the study was to investigate the impact of placental cord drainage during the third stage of labor on the amount of maternal bleeding, duration of the third stage, and incidence of postpartum hemorrhage. A randomized controlled trial was conducted at a high-volume tertiary obstetric center between May 2021 and December 2022. A total of 212 pregnant women with a singleton uncomplicated pregnancy were randomly assigned to undergo placental cord drainage or standard care without drainage. The randomization was manual, using pre-marked cards drawn by the participants. The power calculation determined a sample size of 92 participants per group to achieve 80% power at a 5% significance level, aiming to detect 20% difference in bleeding amount between the groups. In practice, we included more than 100 women in each group. The primary outcome was the amount of bleeding during the third stage of labor, while secondary outcomes included the duration of the third stage and incidence of postpartum hemorrhage. After delivery, all participants received 10 units of oxytocin via intravenous drip and delayed cord clamping was performed. In the study group, the maternal umbilical cord was then unclamped. Blood was allowed to drain into a plastic bag placed under the women's buttocks. If an episiotomy or perineal tear was observed, pressure packing was applied to reduce bleeding. The collected blood was measured in milliliters after placental expulsion. A total of 212 women were recruited of whom 104 underwent placental cord drainage and 108 received standard care without drainage. No significant differences were observed between the intervention and control groups in mean duration of the third stage of labor (10.56±6.12 vs. 10.95±6.33 minutes, P=0.65), incidence of postpartum hemorrhage (3.84% vs. 7.41%, P=0.38), or mean amount of bleeding during the third stage of labor (292±200 vs. 300±242 ml, P=0.79). Furthermore, there were no significant between-group differences in the mean amount of bleeding on separate analysis of nulliparous women (356±246 vs. 330±240 ml, P=0.68), multiparous women (265±171 vs. 289±244 ml, P=0.50), women who were not exposed to external oxytocin during labor (287±204 vs. 317±250 ml, P=0.59), and women who were exposed to external oxytocin (296±198 vs. 289±238 ml, P=0.39). Placental cord drainage during the third stage of labor showed no statistically significant impact on bleeding amount, third-stage length, or postpartum hemorrhage rate. The findings suggest that placental cord drainage may not offer additional benefits in preventing postpartum hemorrhage in women with uncomplicated pregnancies.

Sections du résumé

BACKGROUND BACKGROUND
The third stage of labor is a pivotal phase in obstetric care. Management may be physiological or active. Although the use of prophylactic placental cord drainage has been assessed in prior data, there is still no clear-cut evidence supporting its effectiveness in improving key obstetric outcomes.
OBJECTIVE OBJECTIVE
The aim of the study was to investigate the impact of placental cord drainage during the third stage of labor on the amount of maternal bleeding, duration of the third stage, and incidence of postpartum hemorrhage.
STUDY DESIGN METHODS
A randomized controlled trial was conducted at a high-volume tertiary obstetric center between May 2021 and December 2022. A total of 212 pregnant women with a singleton uncomplicated pregnancy were randomly assigned to undergo placental cord drainage or standard care without drainage. The randomization was manual, using pre-marked cards drawn by the participants. The power calculation determined a sample size of 92 participants per group to achieve 80% power at a 5% significance level, aiming to detect 20% difference in bleeding amount between the groups. In practice, we included more than 100 women in each group. The primary outcome was the amount of bleeding during the third stage of labor, while secondary outcomes included the duration of the third stage and incidence of postpartum hemorrhage. After delivery, all participants received 10 units of oxytocin via intravenous drip and delayed cord clamping was performed. In the study group, the maternal umbilical cord was then unclamped. Blood was allowed to drain into a plastic bag placed under the women's buttocks. If an episiotomy or perineal tear was observed, pressure packing was applied to reduce bleeding. The collected blood was measured in milliliters after placental expulsion.
RESULTS RESULTS
A total of 212 women were recruited of whom 104 underwent placental cord drainage and 108 received standard care without drainage. No significant differences were observed between the intervention and control groups in mean duration of the third stage of labor (10.56±6.12 vs. 10.95±6.33 minutes, P=0.65), incidence of postpartum hemorrhage (3.84% vs. 7.41%, P=0.38), or mean amount of bleeding during the third stage of labor (292±200 vs. 300±242 ml, P=0.79). Furthermore, there were no significant between-group differences in the mean amount of bleeding on separate analysis of nulliparous women (356±246 vs. 330±240 ml, P=0.68), multiparous women (265±171 vs. 289±244 ml, P=0.50), women who were not exposed to external oxytocin during labor (287±204 vs. 317±250 ml, P=0.59), and women who were exposed to external oxytocin (296±198 vs. 289±238 ml, P=0.39).
CONCLUSIONS CONCLUSIONS
Placental cord drainage during the third stage of labor showed no statistically significant impact on bleeding amount, third-stage length, or postpartum hemorrhage rate. The findings suggest that placental cord drainage may not offer additional benefits in preventing postpartum hemorrhage in women with uncomplicated pregnancies.

Identifiants

pubmed: 39098635
pii: S2589-9333(24)00179-4
doi: 10.1016/j.ajogmf.2024.101453
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101453

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicts of interest.

Auteurs

Natav Hendin (N)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: Hendinatav@gmail.com.

Michal Grosvald (M)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ilana Shemesh (I)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Marina Leonenko (M)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Mursi Jbara (M)

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Kinneret Segal (K)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yossi Geron (Y)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Adi Borovich (A)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva.

Rony Chen (R)

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eran Hadar (E)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Asnat Walfisch (A)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ohad Houri (O)

Helen Schneider Hospital for Women, Rabin Medical Center - Beilinson Hospital, Petach Tikva; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Classifications MeSH